glucose, (beta-d)-isomer has been researched along with Infectious Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haniuda, K; Higashiyama, M; Kitamura, D; Kubo, M; Miyauchi, K; Nihei, Y; Suzuki, Y | 1 |
| Guo, JP; Harris, RA; Jennische, E; Lange, S; Lorentzen, JC; Tarkowski, A; Verdrengh, M | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and Infectious Diseases
| Article | Year |
|---|---|
Subcutaneous immunisation with zymosan generates mucosal IgA-eliciting memory and protects mice from heterologous influenza virus infection.
Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Viral; Antigens; Communicable Diseases; Humans; Immunity, Mucosal; Immunization; Immunoglobulin A; Influenza Vaccines; Influenza, Human; Mice; Mucous Membrane; Orthomyxoviridae; Orthomyxoviridae Infections; Toll-Like Receptor 2; Vaccination; Zymosan | 2023 |
The rat antigen-presenting lectin-like receptor complex influences innate immunity and development of infectious diseases.
Topics: Adjuvants, Immunologic; Animals; Arthritis, Infectious; beta-Glucans; Cells, Cultured; Communicable Diseases; Cytokines; Encephalitis; Herpesvirus 1, Human; Hypersensitivity, Delayed; Immunity, Innate; Lectins, C-Type; Lipopolysaccharides; Macrophage Activation; Macrophages; Mannans; Oxazolone; Rats; Staphylococcal Infections; Staphylococcus aureus; Zymosan | 2009 |